1. Clinical & Scientific Overview
Alpha-Lipoic Acid, Coenzyme Q10 (Ubidecarenone) & L-Carnitine (TIP-MED-000201, Reference Code [10.17]) is classified under
Vitamins, Minerals & Nutritional Supplements (Ch 10) as a Mitochondrial Metabolic Coenzymes & Neuropathic/Myopathic Antioxidants (Schedule H / Nutraceutical).
Within the Indian regulatory and compendial framework, it is governed under Non-Schedule / OTC or Schedule K Permitted Preparation (Medical Supervision Recommended for High-Dose/Therapeutic Regimens).
Representative Indian Market Examples (Edition 2.7 Ch 10 [10.17], p. 135): Alpha-Lipoic Acid (ALA): Ala (100/300/600 mg), Thioctacid; FDCs with Methylcobalamin + Pregabalin/Benfotiamine (Nurokind-Plus, Meconeuron OD). Coenzyme Q10: CoQ (100/300 mg), Ubicar. L-Carnitine: Carnitor (500 mg PO / 1 g IV), Evion-LC — Strengths & Dosage Forms: Alpha-Lipoic Acid Tablets/Capsules: 100 mg, 300 mg, 600 mg. Coenzyme Q10 Softgels: 100 mg, 200 mg, 300 mg. L-Carnitine Tablets: 500 mg; Oral Solution: 500 mg/5mL; IV: 1 g/5mL
Alpha-Lipoic Acid Tablets/Capsules: 100 mg, 300 mg, 600 mg. Coenzyme Q10 Softgels: 100 mg, 200 mg, 300 mg. L-Carnitine Tablets: 500 mg; Oral Solution: 500 mg/5mL; IV: 1 g/5mL
3. Mechanism of Action & Pharmacodynamics
Mitochondrial Metabolic Coenzymes & Neuropathic/Myopathic Antioxidants (Schedule H / Nutraceutical) acting on target receptor/enzyme pathways in Vitamins, Minerals & Nutritional Supplements (Ch 10): clinical efficacy is mediated via Mitochondrial Metabolic Coenzymes & Neuropathic/Myopathic Antioxidants (Schedule H / Nutraceutical) for Alpha-Lipoic Acid: Symptomatic diabetic sensorimotor polyneuropathy (600 mg/day reduces burning/lancinating pain scores). Coenzyme Q10: Statin-associated muscle symptoms (SAMS), mitochondrial myopathies, and adjunct in HFrEF (Q-SYMBIO trial). L-Carnitine: Dialysis-related carnitine deficiency/intradialytic muscle cramps, Valproate-induced hepatotoxicity/hyperammonaemia rescue.
4. Therapeutic Indications & Evidence-Supported Uses
- Alpha-Lipoic Acid: Symptomatic diabetic sensorimotor polyneuropathy (600 mg/day reduces burning/lancinating pain scores)
- Coenzyme Q10: Statin-associated muscle symptoms (SAMS), mitochondrial myopathies, and adjunct in HFrEF (Q-SYMBIO trial)
- L-Carnitine: Dialysis-related carnitine deficiency/intradialytic muscle cramps, Valproate-induced hepatotoxicity/hyperammonaemia rescue
🇮🇳 Jurisdiction & Indication Note: Indications and schedules reflect Indian compendial and regulatory records (CDSCO / Indian Pharmacopoeia & NFI / NLEM 2022). Where international reference labels (US FDA DailyMed / NCBI StatPearls) are cited for pharmacokinetic or mechanistic parameters, international approvals do not automatically imply CDSCO approval in India.
5. Educational Dosage Context, Formulations & Administration
Educational Dosing & Regimen Summary: Alpha-Lipoic Acid: 300–600 mg PO Once Daily. Coenzyme Q10: 100–200 mg PO OD–BD. L-Carnitine: 500–1000 mg PO BD–TDS (or 10–20 mg/kg slow IV after each haemodialysis session)
Administration & Meal Timing: OPPOSITE FOOD RULES: (1) Alpha-Lipoic Acid (ALA) should be taken on an EMPTY STOMACH (30 min before breakfast — food and divalent cations [Ca2+, Fe2+, Mg2+] chelate ALA and reduce bioavailability by 30–40%!); (2) Coenzyme Q10 is highly lipophilic and MUST be taken WITH A FAT-CONTAINING MEAL; (3) L-Carnitine is taken with or after meals | ALA: Morning 30m pre-breakfast (or separated from Ca/Fe). CoQ10 & L-Carnitine: With Meals
6. Pharmacokinetics, Metabolism & Renal/Hepatic Adjustment
Absorption, distribution, metabolism, and excretion follow class pharmacokinetic profile; verify patient renal/hepatic function.
Renal: Safe (in haemodialysis, IV L-Carnitine post-dialysis or low-dose oral 500 mg is preferred). Hepatic: Safe (L-Carnitine is protective in Valproate hepatotoxicity)
Renal: Safe (in haemodialysis, IV L-Carnitine post-dialysis or low-dose oral 500 mg is preferred). Hepatic: Safe (L-Carnitine is protective in Valproate hepatotoxicity)
Renal: Safe (in haemodialysis, IV L-Carnitine post-dialysis or low-dose oral 500 mg is preferred). Hepatic: Safe (L-Carnitine is protective in Valproate hepatotoxicity)
7. Contraindications, Precautions & High-Risk Warnings
- ALPHA-LIPOIC ACID INSULIN AUTOIMMUNE SYNDROME (IAS / HIRATA DISEASE) ALERT: Alpha-Lipoic Acid contains sulfhydryl groups that can trigger anti-insulin autoantibodies or directly enhance GLUT-4 glucose uptake, causing spontaneous or postprandial HYPOGLYCAEMIA! Caution with L-Carnitine in seizure disorders
Key Clinical Precautions: Renal: Safe (in haemodialysis, IV L-Carnitine post-dialysis or low-dose oral 500 mg is preferred). Hepatic: Safe (L-Carnitine is protective in Valproate hepatotoxicity)
8. Adverse Effects Profile
- ALA: Mild nausea, epigastric burning, garlic/sulfur-like urine odour. CoQ10: Mild GI upset. L-Carnitine: Nausea, 'fishy' body/urine odour
- Hypoglycaemia / Insulin Autoimmune Syndrome (Alpha-Lipoic Acid — sweating, tremor, confusion!), seizures (rare with rapid IV L-Carnitine)
- Monitor for severe hypersensitivity, organ toxicity, or dose-limiting adverse events.
9. Major Drug–Drug, Drug–Food & Drug–Herb Interactions
- CRITICAL ALPHA-LIPOIC ACID INTERACTIONS: (1) Chelates Iron, Calcium, and Magnesium in the gut -> separate ALA by >=2 hours from Iron/Calcium/Antacids!; (2) Potentiates Insulin and Oral Antidiabetics (monitor blood glucose closely!); (3) Space >=4 hours from Levothyroxine! Coenzyme Q10 is structurally similar to Vitamin K2 and can reduce Warfarin INR!
10. Clinical Monitoring, Patient Counselling & Storage
Clinical & Laboratory Monitoring: Monitor clinical response, baseline renal/hepatic parameters, and relevant serum biomarkers.
Pharmacist Patient Counselling Points:
- Patient Counselling Checklist: Take Alpha-Lipoic Acid 30 minutes before breakfast (and at least 2 hours away from Iron, Calcium, or Thyronorm) and watch for signs of low blood sugar; take CoQ10 softgels with lunch or dinner
- Meal & Clock Timing Instruction: OPPOSITE FOOD RULES: (1) Alpha-Lipoic Acid (ALA) should be taken on an EMPTY STOMACH (30 min before breakfast — food and divalent cations [Ca2+, Fe2+, Mg2+] chelate ALA and reduce bioavailability by 30–40%!); (2) Coenzyme Q10 is highly lipophilic and MUST be taken WITH A FAT-CONTAINING MEAL; (3) L-Carnitine is taken with or after meals (ALA: Morning 30m pre-breakfast (or separated from Ca/Fe). CoQ10 & L-Carnitine: With Meals)
- Missed Dose Protocol: Take at next scheduled slot if missed
- Geriatric Dispensing Pearl: Monitor blood glucose in older diabetic patients taking ALA-containing neuropathy combinations
Storage, Stability & Dispensing Safeguards: Store below 25°C–30°C in original moisture- and light-resistant packaging out of reach of children. Available forms: Alpha-Lipoic Acid Tablets/Capsules: 100 mg, 300 mg, 600 mg. Coenzyme Q10 Softgels: 100 mg, 200 mg, 300 mg. L-Carnitine Tablets: 500 mg; Oral Solution: 500 mg/5mL; IV: 1 g/5mL
11. Visual Pharmacology & Mechanism Diagram (svg-v339-01-adme-12-step-journey)
12. Authoritative References, Regulatory Sources & Editorial Disclaimer
Primary Compendial & Guideline Reference: Indian Pharmacist Desk Reference — Professional Edition 2.7 (2026–27) • Ch 10 [10.17] (p. 135)
Official Verification Portals: Indian Pharmacopoeia Commission (IPC) & National Formulary of India (NFI) • Central Drugs Standard Control Organization (CDSCO) • Ministry of Health & Family Welfare — NLEM 2022 • NCBI Bookshelf / StatPearls Pharmacology Reference • DailyMed (US FDA Official Prescribing Reference)
Last Medically & Pharmaceutically Reviewed: 2026-11-10 • Verification Status: HANDBOOK_SOURCE_CONTENT
Educational & Clinical Disclaimer: This reference profile is published solely for pharmacy education, academic study, and professional clinical reference. It does not substitute for patient-specific clinical judgement, qualified specialist oncology/medical supervision, or official CDSCO/IP prescribing information. Never self-medicate with prescription, Schedule H/H1/X, NDPS, or oncology medicines.
13. Related Reference Monographs, Educational Guides & Visual Concept
💊 Related Pharmacological / Category Profiles
- [10.12] Thiamine Hydrochloride / Benfotiamine (Vitamin B1) — Essential Pyrophosphate Coenzyme for Carbohydrate Decarboxylation
- [10.13] Pyridoxine Hydrochloride (Vitamin B6) — Pyridoxal-5'-Phosphate (PLP) Coenzyme for Amino Acid & Neurotrans
- [10.16] Vitamin A (Retinol Palmitate) & Vitamin E (Tocopheryl Acetate) — Fat-Soluble Retinoid Epithelial/Visual Vitamin & Lipid-Peroxidati
- [10.1]-C100 Cyanocobalamin (Vitamin B12) — Water-Soluble Neurotropic & Haematinic Vitamin (Cobalamin; Coenzy